Distributor inventory | Cream
Fluocinolone acetonide 0.01% w/w + Hydroquinone 4% w/w + Tretinoin 0.05% w/w
Treatment of melasma (facial hyperpigmentation) and short-term management of moderate to severe hyperpigmentation such as dark patches due to sun exposure; used with sun protection measures.
Hydroquinone reduces melanin formation by inhibiting tyrosinase, helping lighten dark patches. Tretinoin increases skin cell turnover and improves penetration of hydroquinone. Fluocinolone (a mild corticosteroid) reduces inflammation and irritation caused by the other ingredients.
For external use only. Apply a thin film to the affected area once daily at night (usually for up to 8 weeks or as directed by a dermatologist). Cleanse and dry skin before application; avoid eyes, mouth, and broken skin. Use broad-spectrum sunscreen and protective clothing during daytime; avoid excessive sun/UV exposure.
Common side effects of TRILUMA CREAM may include:
Use only under medical supervision; not for long-term continuous use. Avoid use on broken/eczema-affected skin and avoid occlusive dressings unless advised. Prolonged or improper use may cause skin atrophy, steroid-related effects, rebound pigmentation, or ochronosis (rare, with hydroquinone). Stop and consult a doctor if severe irritation, swelling, blistering, or allergy occurs. Avoid during active skin infections; treat infection first. Not recommended in children unless prescribed. Strict sun protection is essential.
